GLPBio

Ursocholic acid

Catalog No.: GC33799Purity:>98.00%Synonyms: 7β-Hydroisocholic Acid, 7-Epichoic Acid, 3α,7β,12α-Trihydroxy-5β-cholanoic Acid, UCA
UrsocholsÄure, eine GallensÄure, die vorwiegend in der Galle von SÄugetieren vorkommt, wird bei MÄusen durch die Darmflora in DesoxycholsÄure umgewandelt.

Die Produkte sind ausschließlich für Forschungszwecke bestimmt. Nicht zur Anwendung am Menschen. Wir verkaufen nicht an Patienten.


Ursocholic acid
Cas No.: 2955-27-3
10mM (in 1mL DMSO)In Stock
$76.00
1
1mgIn Stock
$36.00
1
5mgIn Stock
$84.00
1
10mgIn Stock
$126.00
1
25mgIn Stock
$260.00
1
50mgIn Stock
$362.00
1

Zitate (Citations)

Für dieses Produkt sind derzeit keine Zitate verfügbar. Nachfolgend finden Sie ausgewählte Publikationen, die GlpBio-Produkte zitieren.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Beschreibung (Description)

Ursocholic acid is the 7β-hydroxy epimer of cholic acid, with highly hydrophilic[1]. Ursocholic acid can be well absorbed and excreted into the bile in animals, which is converted to deoxycholic acid by intestinal flora[2]. Ursocholic acid has been widely used in comparative studies on the regulation of bile acid secretion and gallstone dissolution[3].

In vivo, Ursocholic acid treatment via feeding at a dose of 5.4g/day for 5 weeks reduced the increase in gallbladder cholesterol and phospholipid levels in mice induced by the lithogenic diet, resulting in increased fecal excretion of deoxycholic acid and cholic acid[4].

References:
[1] Tonin F, Arends I W C E. Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review[J]. Beilstein journal of organic chemistry, 2018, 14(1): 470-483.
[2] Tint S G, Batta A K, Dayal B, et al. Metabolism of ursocholic acid in humans: conversion of ursocholic acid to deoxycholic acid[J]. Hepatology, 1992, 15(4): 645-650.
[3] Howard P J, Gleeson D, Murphy G M, et al. Ursocholic acid: bile acid and bile lipid dose response and clinical studies in patients with gall stones[J]. Gut, 1989, 30(1): 97-103.
[4] Uchida K, Aklyoshi T, Igimi H, et al. Differential effects of ursodeoxycholic acid and ursocholic acid on the formation of biliary cholesterol crystals in mice[J]. Lipids, 1991, 26(7): 526-530.

Protokoll (Protocol)

Animal experiment [1]:

Animal models

ICR strain male mice

Preparation Method

ICR strain male mice, six-weeks-old, were kept in an air-conditioned room (25±1℃; 50-60% humidity) lighted 12 hours a day (8:00 a.m. to 8:00 p.m.). An ordinary powder diet was provided as a basal diet. The lithogenic diet was prepared by adding 0.5% cholesterol and 0.25% sodium cholate to the basal diet. The composition of the basal diet was as follows: 25.5% protein, 4.0% lipids, 53.5% carbohydrate, 4.0% fiber, 7.0% ash, and 6.0% water. The content of cholesterol was about 0.1%. The mice were given ad libitum tap water and lithogenic diet with Ursocholic acid (5.4g/day) for five weeks. Collect mouse samples for analysis.

Dosage form

5.4g/day for 5 weeks; p.o.

Applications

Ursocholic acid treatment significantly reduced biliary bile acid level in mice and increased fecal excretion of deoxycholic acid and cholic acid.

References:
[1] Uchida K, Aklyoshi T, Igimi H, et al. Differential effects of ursodeoxycholic acid and ursocholic acid on the formation of biliary cholesterol crystals in mice[J]. Lipids, 1991, 26(7): 526-530.

Produktdokumente (Product Documents)

Purity:>98.00%Appearance:A solid

Chemische Eigenschaften (Chemical Properties)

CAS-Nr.
2955-27-3
Synonyme
7β-Hydroisocholic Acid, 7-Epichoic Acid, 3α,7β,12α-Trihydroxy-5β-cholanoic Acid, UCA
SMILES
C[C@H](CCC(O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C
Summenformel
C24H40O5
Molekulargewicht
408.57
Löslichkeit
DMSO : 100 mg/mL (244.76 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)
Lagerung
Store at -20°C
Allgemeine Hinweise
Wählen Sie anhand der Löslichkeitsdaten des Produkts ein geeignetes Lösungsmittel. Aliquotieren Sie die Stammlösung nach der Herstellung, um wiederholte Gefrier-Auftau-Zyklen zu vermeiden.
Verwenden Sie Stammlösungen bei Lagerung bei -80°C innerhalb von 6 Monaten bzw. bei -20°C innerhalb von 1 Monat.
Zur Verbesserung der Löslichkeit das Röhrchen auf 37°C erwärmen und für eine angemessene Dauer beschallen.
Versandbedingungen
Evaluierungsmuster werden mit Kühlakkus versandt. Andere verfügbare Größen werden bei Raumtemperatur oder auf Anfrage mit Kühlakkus versandt.

Rechner (Calculators)Molarität / Verdünnung / Molekulargewicht / Einheitenumrechnung / In-vivo-Formulierung / Löslichkeit

g/mol

Reviews

Review for Ursocholic acid

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%